EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

People who inject drugs and men who have sex with men living with HIV in India experience low probability of viral rebound and high levels of persistent viremia during the first 12 months of antiretroviral therapy

Talia A Loeb, Sunil S Solomon, Mihili P Gunaratne, A K Srikrishnan, C K Vasudevan, Rifa T Khan, Santhanam Anand, Boobalan Jayaseelan, Muniratnam Suresh Kumar, David D Celentano, Gregory M Lucas, Shruti H Mehta und 1 weitere

AIDS Care · 2025

DOI: 10.1080/09540121.2025.2484635 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift AIDS Care, 2025. Verfasst von Talia A Loeb und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. Hauptthemen laut MEDLINE: HIV Infections, Homosexuality, Male, Viremia, Substance Abuse, Intravenous. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, NIAID NIH HHS, National Institute on Drug Abuse.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

People who inject drugs (PWID) and men who have sex with men (MSM) in India are disproportionately affected by HIV and experience challenges achieving sustained viral suppression. We evaluated probabilities of suppression over time and characteristics associated with persistent viremia and viral rebound among MSM and PWID living with HIV (PLHIV) using 12 months of data collected between 2017-2019 from a cluster-randomized trial across 16 cities in India. To assessprobabilities of suppression, we fit logistic transition models with generalized estimating equations. To assess correlates of persistent viremia and viral rebound, we fit multivariable multilevel logistic regression models. Of 750 PWID, 88% were male and 14% completed high school. Of 850 MSM, 29% completed high school and 54% were married. 46% of PWID and 67% of MSM maintained viral suppression once achieved. Probabilities of viral rebound decreased over time. The probability of newly achieving suppression decreased, from 33%-12% after six months among PWID and 60%-13% among MSM. Among PWID, correlates of persistent viremia included lower education, employment, homelessness, and active injection. Among MSM, hazardous alcohol use was associated with viremia and viral rebound. Treatment engagement and support efforts need to be intensified to encourage PLHIV to achieve life-long suppression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsHomosexuality, MaleViremiaSubstance Abuse, IntravenousAnti-HIV AgentsHumansMaleIndiaAdultViral LoadMiddle Aged

Stichwörter der Autor:innen

HIVHIV viral suppressionIndiaSDG10: reduced inequalitiesSDG3: good health and well-beingmen who have sex with menpeople who inject drugsviral rebound

Substanzen

Anti-HIV Agents

Autor:innen und Institutionen

  • Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • YR Gaitonde Centre for AIDS Research and Education, Chennai, India.

Förderung

  • NIDA NIH HHS
  • NIAID NIH HHS
  • National Institute on Drug Abuse
  • National Institutes of Health
  • Johns Hopkins Center for AIDS Research
  • Elton John AIDS Foundation

Zitieren

APA

Loeb, T. A., Solomon, S. S., Gunaratne, M. P., Srikrishnan, A. K., Vasudevan, C. K., Khan, R. T., Anand, S., Jayaseelan, B., Kumar, M. S., Celentano, D. D., Lucas, G. M., Mehta, S. H., & McFall, A. M. (2025). People who inject drugs and men who have sex with men living with HIV in India experience low probability of viral rebound and high levels of persistent viremia during the first 12 months of antiretroviral therapy. AIDS Care. https://doi.org/10.1080/09540121.2025.2484635

Vancouver

Loeb TA, Solomon SS, Gunaratne MP, Srikrishnan AK, Vasudevan CK, Khan RT, et al. People who inject drugs and men who have sex with men living with HIV in India experience low probability of viral rebound and high levels of persistent viremia during the first 12 months of antiretroviral therapy. AIDS Care. 2025. doi:10.1080/09540121.2025.2484635

BibTeX
@article{Loeb2025,
  author = {Loeb, Talia A and Solomon, Sunil S and Gunaratne, Mihili P and Srikrishnan, A K and Vasudevan, C K and Khan, Rifa T and Anand, Santhanam and Jayaseelan, Boobalan and Kumar, Muniratnam Suresh and Celentano, David D and Lucas, Gregory M and Mehta, Shruti H and McFall, Allison M},
  title = {People who inject drugs and men who have sex with men living with HIV in India experience low probability of viral rebound and high levels of persistent viremia during the first 12 months of antiretroviral therapy},
  journal = {AIDS Care},
  year = {2025},
  doi = {10.1080/09540121.2025.2484635}
}
Kostenlos starten →